Skip to main content

Table 4 SNPs found to be associated with higher breast cancer risk for BRCA2 pathogenic variants carriers

From: Insights into genetic modifiers of breast cancer risk in carriers of BRCA1 and BRCA2 pathogenic variants

Gene

Locus

SNP

Sample size

Unaffected/

Affected

HR (95% CI)

P-value

Genotyping platform

Function

Ref

RAD51

15q15.1

rs1801320

2748

1174/1574

3.18 (1.39–7.27)

0.0004

TaqMan, RFLP-PCR

DNA repair through homologous recombination

[14]

TOX3/

TNRC9

16q12.1

rs3803662

3255

1426/1829

1.15 (1.03–1.27)

0.009

iPLEX, TaqMan

Chromatin remodelling

[15]

FGFR2

10q26.13

rs2981582

3260

1427/1833

1.32 (1.20–1.45)

1.7 × 10− 8

iPLEX, TaqMan

Cell growth and differentiation

[15]

ALDH2

12q24.12

rs10744777

19 488

11,873/7615

1.72 (1.19–2.48)

0.003

TaqMan

Detoxification of acetaldehyde

[30]

LSP1

11p15.5

rs3817198

5434

2404/3030

1.16 (1.07–1.25)

2.8 × 10− 4

iPLEX,, TaqMan

Immune cell signalling and adhesion

[13]

MAP3K1

5q11.2

rs889312

3524

1557/1967

1.12 (1.02–1.24)

0.020

iPLEX, TaqMan

Regulation of cell migration

[15]

LOC134997

6q22

rs9393597

2006

887/1119

1.55 (1.25–1.92)

6.0 × 10− 5

Illumina

Non-coding RNA (IncRNA) family, regulation of gene expressions

[29]

FBXL7

5p15.1

rs12652447

2006

887/1119

1.37 (1.16–1.62)

1.7 × 10− 4

Illumina

Regulation of protein degradation

[29]

SMAD3

15q22

rs3825977

2693

1189/1504

1.20 (1.03–1.40)

0.018

Illumina, iPLEX

TGF- β signalling pathway

[28]

SMAD3

15q22

rs7166081

2693

1189/1504

1.25 (1.07–1.45)

0.004

Illumina, iPLEX

TGF- β signalling pathway

[28]

EMBP1

1p11.2

rs11249433

6250

2827/3423

1.09 (1.02–1.17)

0.015

iPLEX,, TaqMan

IcnRNA class, regulation of gene expression

[11]

SLC4A7/

NEK10

3p22

rs4973768

6153

2783/3370

1.10 (1.03–1.18)

6.4 × 10− 3

iPLEX, TaqMan

Ion transport, protein phosphorylation

[10]

FGF10/

MRPS30

5p12

rs10941679

5854

2591/3263

1.09 (1.01–1.19)

0.032

iPLEX TaqMan

Cell growth, regulation of mitochondrial function

[10]

ESR1

6q25.1

rs9397435

7117

3313/3804

1.14 (1.01–1.28)

0.031

iPLEX, TaqMan

Mediating the effect of the estrogen on various target tissues

[11]

FGF13

Xq27.1

rs619373

8207

3881/4326

1.30 (1.17–1.45)

3.1 × 10− 6

iCOGS

Embryonic development, cell growth

[21]